Active Pharmaceutical Ingredients (API) Market in India 2015-2019: Key Vendors are Aurobindo Pharma, Cipla and Dr. Reddy's Laboratories

News provided by

Jan 29, 2015, 04:31 ET

DUBLIN, Jan. 29, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/3qwf7j/active) has announced the addition of the "Active Pharmaceutical Ingredients (API) Market in India 2015-2019" report to their offering.

Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis.

The analysts forecast the API market in India to grow at a CAGR of 10.76 percent over the period 2014-2019.

This report covers the present scenario and the growth prospects of the API market in India during the period 2014-2019. To calculate the market size, the report considers the revenue generated from the sales of API by vendors in the market. The report provides the vendor landscape and a corresponding detailed analysis of the top three vendors in the market. The market segmentation data and analysis is also provided for the following segmentation types: type of production process and area of therapy.

In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

The report, the API Market in India 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

One major trend emerging in this market is the strong focus on the development and introduction of high-potency API. Such products are increasingly used in oncology and for the provision of targeted therapy.

According to the report, one of the key drivers contributing to the growth of the API market in India is the increased outsourcing of API by global pharmaceutical companies to low-cost vendors in India. This is done to reduce both manufacturing and infrastructure costs.

Further, the report states that stringent regulations are one of the major challenges that the market faces. Such regulations are particularly well defined for the export of products to developed regions such as Western Europe and North America. Vendors are required to comply with elaborate procedures prior to product commercialization.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. API Market in India

08. Market Segmentation by Type of Production Process

09. Market Segmentation by Area of Therapy

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

18. Key Vendor Analysis

19. Other Reports in this Series

Companies Mentioned: